Marc Suárez-Calvet
Marc Suárez-Calvet
BarcelonaBeta Brain Research Center
Verified email at
Cited by
Cited by
Propagation of tau pathology in a model of early Alzheimer's disease
A De Calignon, M Polydoro, M Suárez-Calvet, C William, DH Adamowicz, ...
Neuron 73 (4), 685-697, 2012
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury
M Suárez-Calvet, MÁ Araque Caballero, G Kleinberger, RJ Bateman, ...
Science translational medicine 8 (369), 369ra178-369ra178, 2016
Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline
J Lantero Rodriguez, TK Karikari, M Suárez-Calvet, C Troakes, A King, ...
Acta neuropathologica 140, 267-278, 2020
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
TK Karikari, AL Benedet, NJ Ashton, J Lantero Rodriguez, A Snellman, ...
Molecular psychiatry 26 (2), 429-442, 2021
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ …
M Suárez‐Calvet, TK Karikari, NJ Ashton, J Lantero Rodriguez, ...
EMBO molecular medicine 12 (12), e12921, 2020
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
M Ewers, N Franzmeier, M Suárez-Calvet, E Morenas-Rodriguez, ...
Science translational medicine 11 (507), eaav6221, 2019
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
Y Deming, F Filipello, F Cignarella, C Cantoni, S Hsu, R Mikesell, Z Li, ...
Science translational medicine 11 (505), eaau2291, 2019
Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum
AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ...
JAMA neurology 78 (12), 1471-1483, 2021
The FTD‐like syndrome causing TREM 2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism
G Kleinberger, M Brendel, E Mracsko, B Wefers, L Groeneweg, X Xiang, ...
The EMBO Journal 36 (13), 1837-1853, 2017
Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology
M Suárez-Calvet, E Morenas-Rodríguez, G Kleinberger, K Schlepckow, ...
Molecular neurodegeneration 14, 1-14, 2019
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes
N Setó-Salvia, J Clarimón, J Pagonabarraga, B Pascual-Sedano, ...
Archives of neurology 68 (3), 359-364, 2011
Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease
A Moscoso, MJ Grothe, NJ Ashton, TK Karikari, JL Rodríguez, A Snellman, ...
JAMA neurology 78 (4), 396-406, 2021
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy
N Badiola, RM de Oliveira, F Herrera, C Guardia-Laguarta, SA Goncalves, ...
PloS one 6 (10), e26609, 2011
Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
A Moscoso, MJ Grothe, NJ Ashton, TK Karikari, JL Rodriguez, A Snellman, ...
Brain 144 (1), 325-339, 2021
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ...
Human molecular genetics 23 (3), 749-754, 2014
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
NJ Ashton, A Hye, AP Rajkumar, A Leuzy, S Snowden, M Suárez-Calvet, ...
Nature Reviews Neurology 16 (5), 265-284, 2020
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease
MÁ Araque Caballero, M Suárez-Calvet, M Duering, N Franzmeier, ...
Brain 141 (10), 3065-3080, 2018
Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
The system can't perform the operation now. Try again later.
Articles 1–20